Author’s Reply to: Comment: Translating Guidelines Into Practice: Interpreting the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

Laura H. Waite; Yvonne L. Phan; Sarah A. Spinler

doi:10.1177/1060028017732359

Author’s Reply to: Comment: Translating Guidelines Into Practice: Interpreting the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

Laura H. Waite
, Yvonne L. Phan
, Sarah A. Spinler

Pharmacy Practice

Binghamton University

University of Sciences in Philadelphia

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	92-93
Number of pages	2
Journal	Annals of Pharmacotherapy
Volume	52
Issue number	1
DOIs	https://doi.org/10.1177/1060028017732359
State	Published - Jan 1 2018

Access to Document

10.1177/1060028017732359

Fingerprint

Dive into the research topics of 'Author’s Reply to: Comment: Translating Guidelines Into Practice: Interpreting the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk'. Together they form a unique fingerprint.

Cite this

Waite, L. H., Phan, Y. L., & Spinler, S. A. (2018). Author’s Reply to: Comment: Translating Guidelines Into Practice: Interpreting the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk. Annals of Pharmacotherapy, 52(1), 92-93. https://doi.org/10.1177/1060028017732359

Waite, Laura H. ; Phan, Yvonne L. ; Spinler, Sarah A. / Author’s Reply to : Comment: Translating Guidelines Into Practice: Interpreting the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk. In: Annals of Pharmacotherapy. 2018 ; Vol. 52, No. 1. pp. 92-93.

@article{7357fd4c554c46ec859fe385dd980b19,

title = "Author{\textquoteright}s Reply to: Comment: Translating Guidelines Into Practice: Interpreting the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk",

author = "Waite, \{Laura H.\} and Phan, \{Yvonne L.\} and Spinler, \{Sarah A.\}",

year = "2018",

month = jan,

day = "1",

doi = "10.1177/1060028017732359",

language = "English",

volume = "52",

pages = "92--93",

journal = "Annals of Pharmacotherapy",

issn = "1060-0280",

publisher = "SAGE Publications Inc.",

number = "1",

}

Waite, LH, Phan, YL & Spinler, SA 2018, 'Author’s Reply to: Comment: Translating Guidelines Into Practice: Interpreting the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk', Annals of Pharmacotherapy, vol. 52, no. 1, pp. 92-93. https://doi.org/10.1177/1060028017732359

Author’s Reply to: Comment: Translating Guidelines Into Practice: Interpreting the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk. / Waite, Laura H.; Phan, Yvonne L.; Spinler, Sarah A.
In: Annals of Pharmacotherapy, Vol. 52, No. 1, 01.01.2018, p. 92-93.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Author’s Reply to

T2 - Comment: Translating Guidelines Into Practice: Interpreting the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

AU - Waite, Laura H.

AU - Phan, Yvonne L.

AU - Spinler, Sarah A.

PY - 2018/1/1

Y1 - 2018/1/1

UR - https://www.scopus.com/pages/publications/85035758878

U2 - 10.1177/1060028017732359

DO - 10.1177/1060028017732359

M3 - Letter

C2 - 28922930

SN - 1060-0280

VL - 52

SP - 92

EP - 93

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

IS - 1

ER -

Waite LH, Phan YL, Spinler SA. Author’s Reply to: Comment: Translating Guidelines Into Practice: Interpreting the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk. Annals of Pharmacotherapy. 2018 Jan 1;52(1):92-93. doi: 10.1177/1060028017732359

Author’s Reply to: Comment: Translating Guidelines Into Practice: Interpreting the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

Access to Document

Other files and links

Fingerprint

Cite this